MedTrace Logo

Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer

NCT01048918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2023-07-05

No results posted yet for this study

Summary

The purpose of this study is to identify tumor cells in the bloodstream (Circulating Tumor Cells, CTC's) from patient's with locally advanced or metastatic (stage IV) breast cancer. Analyzing the tumor is helpful in guiding therapy; however, research has suggested that the number of tumor cells found in the bloodstream (CTC's) signifies more aggressive behavior and increased difficulty in eliminating the cancer. This research will help to develop better ways to treat breast cancer which could be tailored to a patient and may be adjusted to a patient's individual needs.

Conditions

  • Locally Advanced Breast Cancer
  • Metastatic (Stage IV) Breast Cancer
  • Stage III-IV Breast Cancer or Inflammatory

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Palo Alto Research Center

    collaborator OTHER

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Yuan Yuan, MD, PhD · City of Hope Medical Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-04
Primary Completion
2022-04-08
Completion
2022-04-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01048918 on ClinicalTrials.gov